Clinical trial
Clinical Impact of Dedicated MR Staging of Ovarian Cancer
NCT03399344 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Impact of Dedicated MR Staging of Ovarian Cancer
- Lead sponsor
- The Netherlands Cancer Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 13, 2018
- Completion date
- July 1, 2022
- Enrollment
- 270 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer